What are the recommended dose, indications, and contraindications for tumescent anesthesia?

Tumescent Anesthesia: Dose, Indications, and Contraindications

For tumescent anesthesia in office-based liposuction, use lidocaine with epinephrine at a maximum dose of 55 mg/kg for patients weighing 43.6-81.8 kg, with lidocaine being the preferred agent over prilocaine (which is not FDA-approved for this use in the United States) and bupivacaine (which is not recommended). 1

Recommended Dosing

For Liposuction Procedures

• Maximum dose: 55 mg/kg of lidocaine with epinephrine (Level I evidence, Strength A recommendation) 1
• This dosing is validated only for patients weighing 43.6-81.8 kg 1
• Safety outside this weight range has not been confirmed
• Epinephrine concentration: 0.25-1.5 mg/L in tumescent solution 2
• Total epinephrine should not exceed 50 mcg/kg 2

For Non-Liposuction Procedures

The maximum safe dose is significantly lower: 28 mg/kg of lidocaine with epinephrine 3, 4

This critical distinction exists because liposuction physically removes the anesthetic-containing fat, reducing systemic absorption. Without liposuction, the entire dose remains in the body and absorbs systemically over time.

Important Pharmacokinetic Considerations

• Peak serum lidocaine concentrations occur 12-16 hours after injection when used with epinephrine for liposuction 3
• Without epinephrine, peaks occur much earlier (1-2 hours) 3
• The delayed absorption pattern means toxicity can manifest many hours post-procedure
• All measured concentrations should remain below 6 mcg/mL (the threshold for mild toxicity) 4

Primary Indication

Office-based liposuction is the primary FDA-approved and evidence-based indication for tumescent anesthesia 1

Other Dermatologic Applications

While used off-label for various procedures, the evidence is strongest for:

• Localized fat deposits (abdomen, thighs, buttocks, male breasts for novices) 2
• Follicular unit hair transplantation (combined with other local anesthesia) 1
• Axillary hyperhidrosis (after adequate experience) 2

Not recommended for treatment of obesity 2

Contraindications

Absolute Contraindications

• Severe cardiovascular disease 2, 5
• Severe coagulation disorders including thrombophilia 2
• Pregnancy 2
• Cardiac or pulmonary risk factors (particularly in outpatient settings) 5

Relative Contraindications

• Patients outside the validated weight range (43.6-81.8 kg) require extreme caution as safety data is lacking 1
• True lidocaine allergy (use ester-type anesthetics, bacteriostatic saline, or 1% diphenhydramine as alternatives) 1

Agent Selection

Recommended Agents

1. Lidocaine with epinephrine (first-line, Level I-II evidence, Strength A) 1
2. Prilocaine (safe and effective but NOT FDA-approved in the US for this indication) 1
   • Consider combining lidocaine and prilocaine to reduce toxicity risk when large volumes are needed 1

Not Recommended

• Bupivacaine: No data supporting its use; not recommended 1

Administration Technique to Minimize Complications

Pain Reduction Strategies

• Use warm solution (40°C) (Level II evidence, Strength B) 1
• Slow infiltration rate (Level III evidence, Strength C) 1

Safety Measures to Prevent Local Anesthetic Systemic Toxicity (LAST)

1. Use the lowest effective dose
2. Aspirate before each injection to avoid intravascular administration
3. Use incremental injections
4. Continuously monitor and communicate with the patient for early toxicity signs 1

Critical Monitoring Requirements

During Procedure

• Baseline vital signs (blood pressure, heart rate)
• Pulse oximetry is essential in all cases 2
• Continuous patient assessment for signs of toxicity

Post-Procedure

• Extended monitoring is mandatory due to delayed peak absorption (12-16 hours) 3
• Patients should be observed by adequately trained staff for a sufficient period 5
• Watch for signs of lidocaine toxicity, epinephrine effects (tachycardia, arrhythmias, hypertension), and fluid overload 5

Emergency Preparedness

• Lipid emulsion therapy must be readily available for LAST treatment 3, 6
• Emergency resuscitation equipment and trained personnel required 2
• Anesthesiologist standby is recommended but not mandatory 2

Common Pitfalls to Avoid

1. Do not exceed 55 mg/kg even for liposuction - this is the maximum validated safe dose 1
2. Do not use the 55 mg/kg dose for non-liposuction procedures - use 28 mg/kg maximum instead 3, 4
3. Do not combine liposuction with other procedures if it would exceed maximum lidocaine dosage 2
4. Do not discharge patients too early - toxicity can manifest 12-16 hours post-injection 3
5. Do not remove more than 5000 mL of fat in a single session 2
6. Do not perform mega-liposuctions - they are not recommended 2

Post-Operative Care

• Antibiotics for 5 days (agent selection per physician preference) 2
• Cox-2 inhibitors for 5-7 days 2
• Compression garments for 2 weeks (reduces bruising, hematomas, seromas, pain) 2